KitShield is a medical-grade sterile instrument transfer tray that eliminates the primary cause of surgical wrap failure in NHS hospitals.
Every day in NHS hospitals, CSSD staff carry sterile wrapped surgical instrument sets by gripping the wrap directly. The mechanical shear force tears the barrier. A torn wrap means the set is no longer sterile. It goes back for full reprocessing. Theatre lists are delayed. Operations are cancelled.
This has been documented in peer-reviewed clinical literature for decades. It has never been solved — because the dominant supplier sells everything used in the reprocessing cycle. Every failure is revenue to them.
A medical-grade polypropylene sterile instrument transfer tray. Staff grip the handles — not the wrap. The set is enclosed on all four sides. The problem disappears.
Click & drag to rotate
Every operating theatre in the world has this problem. KitShield enters UK first, then Europe, then the Middle East, then the USA — each via established medical device distributors with existing hospital relationships.
| Year | Revenue | EBITDA | Margin |
|---|---|---|---|
| 2026 | £83K | £27K | 33% |
| 2027 | £297K | £144K | 49% |
| 2028 | £711K | £415K | 58% |
| 2029 | £1.77M | £1.28M | 73% |
| 2030 | £3.58M | £2.78M | 78% |
| 2031 | £6.46M | £5.25M | 81% |
Theodore Conway spent nearly two years as an orthopaedic sales representative working directly inside NHS operating theatres and CSSD departments across multiple trusts. Every day he watched wrapped surgical instrument sets being dragged across surfaces, dropped, and roughly handled by staff who had no safe way to carry them.
He watched the consequences — wrap tears, reprocessing cycles, delayed theatre lists and cancelled operations. He never encountered a product designed to eliminate this problem. KitShield is the product he built from that direct clinical observation.
His background gives him immediate peer-to-peer credibility with CSSD managers and theatre procurement teams — the exact people who buy this product.
We are raising £150,000 SEIS at a £1,000,000 post-money valuation. SEIS qualification means 50% income tax relief, zero CGT on exit, and maximum downside protection for investors.